Replies to post #118872 on Biotech Values

[jb_118]

For all practical purposes, it’s a short-lived trust fund for Telaprevir profits.

OT, but it actually has occurred to me that this is the way MNTA has been trading, with generic copaxone a black box, hypothetical T-enox looming (although this seems to be fading) and no visible movement in any other programs for quite some time.

[DewDiligence]

Oops—looks like I was at least one day too early :- (

[ghmm]

Today's Advisory Committee Info:

Docs:
http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AntiviralDrugsAdvisoryCommittee/ucm247236.htm

Free Webcast (According to http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AntiviralDrugsAdvisoryCommittee/UCM252557.pdf)
The meeting webcast can be accessed at the following web address: https://collaboration.fda.gov/adac428/

AF's blog will probably be up soon but couldn't find it should be link here:
http://www.thestreet.com/author/1352996/AdamFeuerstein/all.html